Apollon Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 16.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,658 shares of the financial services provider’s stock after buying an additional 1,195 shares during the period. Apollon Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the business. Golden State Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $128,000. Strategic Financial Concepts LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $1,375,000. Telos Capital Management Inc. boosted its position in iShares Biotechnology ETF by 1.9% during the fourth quarter. Telos Capital Management Inc. now owns 10,999 shares of the financial services provider’s stock valued at $1,454,000 after purchasing an additional 209 shares during the last quarter. Nvwm LLC grew its stake in iShares Biotechnology ETF by 96.4% in the fourth quarter. Nvwm LLC now owns 1,493 shares of the financial services provider’s stock valued at $197,000 after purchasing an additional 733 shares in the last quarter. Finally, Massachusetts Wealth Management acquired a new position in iShares Biotechnology ETF in the 4th quarter worth about $270,000. 62.45% of the stock is owned by hedge funds and other institutional investors.
iShares Biotechnology ETF Stock Down 1.1 %
IBB opened at $136.15 on Tuesday. The business has a 50-day moving average of $136.10 and a 200-day moving average of $141.27. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.
iShares Biotechnology ETF Cuts Dividend
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading
- Five stocks we like better than iShares Biotechnology ETF
- 3 REITs to Buy and Hold for the Long Term
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Stock Sentiment Analysis: How it Works
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
